Age is a major risk factor for geographic atrophy (GA). As the eyes age, natural defenses weaken, blood flow may decline, and waste removal may slow, allowing deposits called drusen to build up.

Muscle atrophy is a primary characteristic of both sarcopenia and cachexia, significantly impacting physical function and quality of life. This figure illustrates the multifaceted causes of muscle ...

While there is currently no cure for geographic atrophy, certain treatments, such as complement inhibitors, can help slow its progression by targeting immune system activity that damages the macula.

With the intensification of global population aging, muscle atrophy, characterized by the loss of muscle mass and function, has become an important health issue affecting the elderly. Researchers have ...

Muscle atrophy models are crucial for understanding disease mechanisms and developing treatments. These models are used to study various interventions, such as exercise and nutrition, drug development ...

Geographic atrophy (GA), the late stage of age-related macular degeneration (AMD), may lead to vision loss. Here’s what to expect as the condition progresses. About 1 million people in the United ...

Regardless of efforts taken to slow disease progression, in the absence of a curative option to either entirely halt progression or repair the damage to the retina, patients with geographic atrophy ...

Before approval of the two intravitreal treatments for geographic atrophy (GA), the only evidence‑based intervention for slowing down progression of age-related macular degeneration (AMD) into more ...